BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29723898)

  • 1. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.
    Marchesini G; Avagnina S; Barantani EG; Ciccarone AM; Corica F; Dall'Aglio E; Dalle Grave R; Morpurgo PS; Tomasi F; Vitacolonna E
    J Endocrinol Invest; 2005 Apr; 28(4):333-9. PubMed ID: 15966506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers.
    Sesti G; Fiorentino TV; Hribal ML; Sciacqua A; Perticone F
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1182-7. PubMed ID: 23419734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
    Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Zhang Y; Lu X; Hong J; Chao M; Gu W; Wang W; Ning G
    Endocrine; 2010 Oct; 38(2):181-7. PubMed ID: 20972737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?
    Sargin M; Uygur-Bayramiçli O; Sargin H; Orbay E; Yayla A
    J Clin Gastroenterol; 2003; 37(5):399-402. PubMed ID: 14564188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
    Ricci G; Bersani G; Rossi A; Pigò F; De Fabritiis G; Alvisi V
    Obes Surg; 2008 Nov; 18(11):1438-42. PubMed ID: 18369681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver enzymes but not free fatty acid levels predict markers of insulin sensitivity in overweight and obese, nondiabetic adults.
    Gray B; Muhlhausler BS; Davies PS; Vitetta L
    Nutr Res; 2013 Oct; 33(10):781-8. PubMed ID: 24074735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of middle-aged mother's but not father's body mass index with 18-year-old son's waist circumferences, birth weight, and serum hepatic enzyme levels.
    Kazumi T; Kawaguchi A; Yoshino G
    Metabolism; 2005 Apr; 54(4):466-70. PubMed ID: 15798952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.
    Bulum T; Kolarić B; Duvnjak L; Duvnjak M
    Dig Dis Sci; 2011 Dec; 56(12):3655-63. PubMed ID: 21735081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes.
    Shin JY; Kim SK; Lee MY; Kim HS; Ye BI; Shin YG; Baik SK; Chung CH
    Diabetes Res Clin Pract; 2011 Oct; 94(1):156-62. PubMed ID: 21862168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
    Sterling RK; Smith PG; Brunt EM
    J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
    Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
    Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.